Nanosight
http://www.youtube.com/watch?v=DMdvmHI4wsg
Malvern Instruments
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2013/Malvern.pdf{/aridoc}
Avacta Analytical
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2013/Avacta.pdf{/aridoc}
Susanne Jörg
Novartis Pharma AG, Switzerland – susanne.joerg@novartis.com Special aspects in the pharmaceutical development of protein formats beyond mAbs In the past decades, monoclonal antibodies have become the fastest growing area of biopharmaceutical industry. Currently, alternative protein formats – such as FAbs, scFvs, nanobodies, etc – are under development. These new antibody and therapeutic protein formats come along with […]
An atomic force microscopy based method for biopharmaceutical stability determination
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2012/posters/croad.pdf{/aridoc}
Malvern Instruments
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2012/exhibitors/malvern-instruments.pdf{/aridoc}
Protein Simple
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2012/exhibitors/protein-simple.pdf{/aridoc}
Challenges in the measurement of protein zeta potential
coming soon
Dr. Natalia Markova
GE Healthcare – Natalia.Markova@ge.com Use of ITC/DSC for the studies of biomolecular stability and interaction of excipients with proteins Stability of liquid protein formulation is critical for achieving desired therapeutic effect during prolonged storage of biopharmaceuticals. Our ability to predict factors critical to protein stability is limited due to a complex nature of proteins and a […]
Protein Simple
{aridoc engine=”google” width=”600″ height=”700″}images/mibio2012/exhibitors/protein-simple.pdf{/aridoc}